Intensity-modulated Radiotherapy Market by Radiation Type (Photon,Electron Beam, Proton and Carbon-Ion Radiation) Application (Prostate, Lung, Breast), End Users ( Hospitals and Independent Radiotherapy centers), and Region - Global Forecasts to 2028
The global intensity-modulated radiotherapy market is projected to reach USD 2.8 billion by 2028 from USD 2.2 billion in 2023, growing at a CAGR of 5.2% during the forecast period. The projected surge in market growth for the Intensity-modulated radiotherapy market (IMRT) is underpinned by a confluence of compelling advantages. Notably, IMRT ‘capacity to achieve exceptional precision in tumor targeting, coupled with its ability to mitigate collateral damage to healthy tissues, stands as a pivotal driver. Furthermore, the escalating global incidence of cancer amplifies the demand for advanced treatment modalities, with IMRT positioned as a forefront solution. This convergence of factors is poised to usher in a phase of robust expansion within the market, consequently shaping the landscape of IMRT adoption in the forthcoming forecasting years.
“The Brain cancer application segment to register highest CAGR over the forecast period of 2023-2027”
Based on the application, the Intensity-modulated radiotherapy market is segmented into prostate cancer, lung cancer, head & neck cancer, breast cancer, gastrointestinal cancer, gynecological cancer, and other applications. The Breast cancer segment is witnessed the highest growth rate In 2022. The increase in breast cancer can be seen due to aging factors, genetic factors like - inherited genetic mutations, such as BRCA1 and BRCA2, contribute to a small percentage of breast cancer cases, the use of hormone replacement therapy can be a few of the potential factors increasing the rate of breast cancers. The incidence of breast cancer may appear to be increasing, but breast cancer mortality rates have been declining due to earlier detection and advances in treatment. IMRT allows physicians and patients to eradicate the cells efficiently by using proper radiation intensity .
“Hospitals’ segment to register for the largest market share of the Intensity-modulated radiotherapy market 2022-2027”
The major end users in the Intensity-modulated radiotherapy market are hospitals. The hospitals end-user segment is estimated to hold a significant market share of the Intensity-modulated radiotherapy market during the forecast period. Hospitals, characterized by their capacity to provide a comprehensive array of medical services within a singular facility, confer a distinctive convenience to patients undergoing the Intensity-modulated radiotherapy market (IMRT). This convenience stems from the consolidation of diverse medical needs under one roof, thereby mitigating the necessity for patients to seek multiple appointments at disparate venues. This strategic amalgamation of services not only streamlines patient care but also augments the attractiveness of IMRT as a preferred treatment option. As a result, this seamless alignment of convenience and comprehensive care significantly contributes to the advancement and prominence of the Intensity-modulated radiotherapy market within hospital settings.
Technological Advances: Hospitals frequently maintain cutting-edge infrastructure and technological capabilities essential for the successful integration of the Intensity-modulated radiotherapy market (IMRT), thus assuring the ready availability of requisite resources. This pivotal attribute distinctly contributes to the advancement and fortification of the image-guided radiation therapy market.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2023-2028, the APAC region is expected to register a significant growth rate in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for image-guided radiation therapy. There are several drivers that contributed to this growth:
The maturing demographic profile observed in APAC countries accentuates the imperative for efficacious cancer treatment modalities characterized by minimized treatment-related adverse effects. This resonance with the precision-driven attributes of the Intensity-modulated radiotherapy market (IMRT) substantiates its pivotal role in enhancing the market landscape.
The incorporation of multilingual patient care offerings within APAC hospitals, combined with the accessibility to advanced treatments like the Intensity-modulated radiotherapy market (IMRT), confers a unique allure to the region, particularly among a diverse patient spectrum. This fusion of linguistic inclusiveness and state-of-the-art medical interventions significantly enhances the region's desirability as a favored healthcare destination, thereby fortifying its competitive position within the healthcare market landscape and concomitantly propelling the prominence of IMRT.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Intensity-modulated radiotherapy market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
“The Brain cancer application segment to register highest CAGR over the forecast period of 2023-2027”
Based on the application, the Intensity-modulated radiotherapy market is segmented into prostate cancer, lung cancer, head & neck cancer, breast cancer, gastrointestinal cancer, gynecological cancer, and other applications. The Breast cancer segment is witnessed the highest growth rate In 2022. The increase in breast cancer can be seen due to aging factors, genetic factors like - inherited genetic mutations, such as BRCA1 and BRCA2, contribute to a small percentage of breast cancer cases, the use of hormone replacement therapy can be a few of the potential factors increasing the rate of breast cancers. The incidence of breast cancer may appear to be increasing, but breast cancer mortality rates have been declining due to earlier detection and advances in treatment. IMRT allows physicians and patients to eradicate the cells efficiently by using proper radiation intensity .
“Hospitals’ segment to register for the largest market share of the Intensity-modulated radiotherapy market 2022-2027”
The major end users in the Intensity-modulated radiotherapy market are hospitals. The hospitals end-user segment is estimated to hold a significant market share of the Intensity-modulated radiotherapy market during the forecast period. Hospitals, characterized by their capacity to provide a comprehensive array of medical services within a singular facility, confer a distinctive convenience to patients undergoing the Intensity-modulated radiotherapy market (IMRT). This convenience stems from the consolidation of diverse medical needs under one roof, thereby mitigating the necessity for patients to seek multiple appointments at disparate venues. This strategic amalgamation of services not only streamlines patient care but also augments the attractiveness of IMRT as a preferred treatment option. As a result, this seamless alignment of convenience and comprehensive care significantly contributes to the advancement and prominence of the Intensity-modulated radiotherapy market within hospital settings.
Technological Advances: Hospitals frequently maintain cutting-edge infrastructure and technological capabilities essential for the successful integration of the Intensity-modulated radiotherapy market (IMRT), thus assuring the ready availability of requisite resources. This pivotal attribute distinctly contributes to the advancement and fortification of the image-guided radiation therapy market.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2023-2028, the APAC region is expected to register a significant growth rate in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for image-guided radiation therapy. There are several drivers that contributed to this growth:
The maturing demographic profile observed in APAC countries accentuates the imperative for efficacious cancer treatment modalities characterized by minimized treatment-related adverse effects. This resonance with the precision-driven attributes of the Intensity-modulated radiotherapy market (IMRT) substantiates its pivotal role in enhancing the market landscape.
The incorporation of multilingual patient care offerings within APAC hospitals, combined with the accessibility to advanced treatments like the Intensity-modulated radiotherapy market (IMRT), confers a unique allure to the region, particularly among a diverse patient spectrum. This fusion of linguistic inclusiveness and state-of-the-art medical interventions significantly enhances the region's desirability as a favored healthcare destination, thereby fortifying its competitive position within the healthcare market landscape and concomitantly propelling the prominence of IMRT.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: C-level–27%, Director-level–18%, and Others–55%
- By Region: North America–50%, Europe–20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%
Research Coverage
- The report studies the Intensity-modulated radiotherapy market based on radiation type, application, end user, and region.
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the global Intensity-modulated radiotherapy market
- The report forecasts the revenue of market segments with respect to five major regions.
The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Intensity-modulated radiotherapy market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
- Analysis of key drivers (increasing prevalence of cancer patient population, Increasing government initiatives for cancer management, advancements in non-invasive treatments through radiation therapy), restraints (Dearth of skilled radiologist/oncologist, high cost of image-guided radiation therapy treatment, Complexity of imaging technology for treatments), opportunities (Expansion of key players in emerging countries, Rising healthcare expenditure across developing countries), and challenges (Availability of alternative technology) influencing the growth of the Intensity-modulated radiotherapy market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the image-guided radiation therapy market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the Intensity-modulated radiotherapy market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Intensity-modulated radiotherapy market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Siemens Healthineers AG (Germany), Elekta (Sweden), and Accuray Incorporated (US), among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SCOPE
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 RECESSION IMPACT: INTENSITY-MODULATED RADIATION THERAPY MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
FIGURE 2 KEY DATA FROM SECONDARY SOURCES
2.1.2.2 Breakdown of primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation
FIGURE 6 COMPANY REVENUE ESTIMATION: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.2.1.2 Customer-based market estimation
FIGURE 7 BOTTOM-UP APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.2.2 TOP-DOWN APPROACH
2.2.3 PRIMARY INTERVIEWS
FIGURE 8 TOP-DOWN APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.3 MARKET ESTIMATION AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 ASSUMPTIONS
2.5.1 STUDY ASSUMPTIONS
2.5.2 ASSUMPTIONS FOR GROWTH FORECAST MODEL
2.6 RISK ASSESSMENT
2.7 IMPACT OF RECESSION ON INTENSITY-MODULATED RADIATION THERAPY MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY REGION, 2022
4 PREMIUM INSIGHTS
4.1 INTENSITY-MODULATED RADIATION THERAPY MARKET OVERVIEW
FIGURE 14 INCREASING PREVALENCE OF CANCER AND GROWING GERIATRIC POPULATION TO DRIVE MARKET
4.2 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE AND COUNTRY
FIGURE 15 PHOTON RADIATION AND US COMMANDED LARGEST MARKET SHARE IN 2022
4.3 REGIONAL SNAPSHOT OF INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 16 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic diseases among all age groups
FIGURE 18 NEW CANCER CASES GLOBALLY, 2020
5.2.1.2 Advancements in radiation therapy technologies to improve treatment and reduce side effects
5.2.1.3 Improved patient outcomes and potential cost savings in long run
5.2.1.4 Reduced infection risk and shorter recovery periods with minimal scarring
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled radiologists/oncologists for operating automated radiotherapy equipment
5.2.2.2 High cost of intensity-modulated radiation therapy systems
5.2.3 OPPORTUNITIES
5.2.3.1 Rapid economic development and rising healthcare expenditure across emerging economies
5.2.3.2 Growing government and private investments in cancer treatment
5.2.3.3 Increased adoption of radiation therapy as primary treatment option for cancer
5.2.4 CHALLENGES
5.2.4.1 Increased risk of radiation exposure for both patients and healthcare staff
5.2.4.2 Increased competition from alternative treatment modalities
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTENSITY-MODULATED RADIATION THERAPY PRODUCTS
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
5.5.1 US
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPEAN COUNTRIES
5.5.3 JAPAN
TABLE 4 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6 REIMBURSEMENT SCENARIO ANALYSIS
TABLE 5 CPT CODES FOR MAJOR INTENSITY-MODULATED RADIATION THERAPY PROCEDURES
TABLE 6 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022
5.7 ECOSYSTEM MARKET MAP
FIGURE 19 ECOSYSTEM MARKET MAP: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.8 VALUE CHAIN ANALYSIS
5.8.1 TECHNOLOGY INNOVATION
5.8.2 PROCUREMENT AND PRODUCT DESIGN
5.8.3 MARKETING, SALES, AND DISTRIBUTION AND POST-SALES SERVICES
FIGURE 20 VALUE CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED COMPANIES
5.9.3 END USERS
FIGURE 21 SUPPLY CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.10 PRICING ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 22 TOP 10 PATENT APPLICANTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 23 TOP 10 PATENT OWNERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
5.12 TECHNOLOGY ANALYSIS
TABLE 7 IMPORTANT PRODUCT LAUNCHES IN INTENSITY-MODULATED RADIATION THERAPY MARKET (JANUARY 2015–JUNE 2022)
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 8 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2023–2024)
6 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION
6.1 INTRODUCTION
TABLE 9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
6.2 PROSTATE CANCER
6.2.1 ADVANCEMENTS IN NONINVASIVE RADIATION THERAPY TECHNOLOGY TO DRIVE MARKET
TABLE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION)
6.3 BREAST CANCER
6.3.1 LIFESTYLE CHANGES AND FOCUS ON EARLY DETECTION THROUGH SCREENING PROGRAMS TO DRIVE MARKET
TABLE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
6.4 LUNG CANCER
6.4.1 INCREASING RESEARCH AND CLINICAL TRIAL ACTIVITY TO DRIVE MARKET
TABLE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION)
6.5 GASTROINTESTINAL CANCER
6.5.1 RISING CONSUMPTION OF SALT-PRESERVED FOOD AND ALCOHOL TO DRIVE MARKET
TABLE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2021–2028 (USD MILLION)
6.6 BRAIN CANCER
6.6.1 NEGLIGENCE IN PRE-SCREENING PROCEDURES TO LIMIT MARKET
TABLE 14 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BRAIN CANCER, BY REGION, 2021–2028 (USD MILLION)
6.7 OTHER CANCERS
TABLE 15 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2021–2028 (USD MILLION)
7 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE
7.1 INTRODUCTION
TABLE 16 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
7.2 PHOTON RADIATION
7.2.1 RISING CANCER CASES GLOBALLY TO DRIVE MARKET
TABLE 17 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PHOTON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.3 ELECTRON RADIATION
7.3.1 TECHNIQUE LIMITATIONS AND REDUCED TREATMENT EFFECTIVENESS TO LIMIT ADOPTION
TABLE 18 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR ELECTRON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.4 PROTON RADIATION
7.4.1 EASY, PRECISE DOSAGE DELIVERY TO CANCEROUS TISSUES TO DRIVE USAGE
TABLE 19 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROTON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.5 CARBON-ION RADIATION
7.5.1 NEED FOR SPECIALIZED FACILITIES AND TREATMENT ROOMS FOR HEAVY ION-BASED THERAPIES TO LIMIT MARKET
TABLE 20 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR CARBON-ION RADIATION, BY REGION, 2021–2028 (USD MILLION)
8 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER
8.1 INTRODUCTION
TABLE 21 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 RAPID ADOPTION OF INVASIVE TECHNOLOGIES AND INCREASED NUMBER OF CANCER PATIENTS TO DRIVE MARKET
TABLE 22 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
8.3 INDEPENDENT RADIOTHERAPY CENTERS
8.3.1 LOWER OVERHEAD COSTS AND SHORTER WAITING PERIOD TO DRIVE MARKET
TABLE 23 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION)
9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 24 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT
TABLE 25 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 US dominated North American intensity-modulated radiation therapy market in 2022
TABLE 29 US: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Increasing prevalence of cancer and high demand for timely diagnosis to drive market
TABLE 30 CANADA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 31 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 33 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Increasing geriatric population and rising life expectancy to drive market
TABLE 35 GERMANY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing government initiatives for better healthcare practices to drive market
TABLE 36 FRANCE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 High burden of cancer and rising preference for noninvasive cancer management to drive market
TABLE 37 UK: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Increasing geriatric population and rising use of noninvasive cancer treatment methods to drive market
TABLE 38 ITALY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing technological developments in healthcare to drive market
TABLE 39 SPAIN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 40 REST OF EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT
TABLE 41 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 JAPAN
9.4.2.1 Increased geriatric population and presence of well-established healthcare sector to drive market
TABLE 45 JAPAN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Growing prevalence of cancer and developing healthcare infrastructure to drive market
TABLE 46 CHINA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing target patient population and rising availability of advanced surgical treatments to drive market
TABLE 47 INDIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Developing healthcare sector with increasing availability of advanced surgical and imaging procedures to drive market
TABLE 48 AUSTRALIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Growing target cancer patient population and increasing awareness of early cancer diagnosis to drive market
TABLE 49 SOUTH KOREA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 50 REST OF ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 51 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 53 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market
TABLE 55 BRAZIL: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Favorable government initiatives and low-cost manufacturing advantages to drive market
TABLE 56 MEXICO: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 57 REST OF LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 FAVORABLE GOVERNMENT INITIATIVES AND ECONOMIC GROWTH TO DRIVE MARKET
TABLE 58 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 26 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2019–2023)
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022)
10.4 MARKET SHARE ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY KEY PLAYER (2022)
FIGURE 28 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2022
10.5 COMPANY EVALUATION MATRIX FOR PLAYERS (2022)
10.5.1 STARS
10.5.2 PERVASIVE PLAYERS
10.5.3 EMERGING LEADERS
10.5.4 PARTICIPANTS
FIGURE 29 COMPANY EVALUATION MATRIX FOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET, 2022
10.6 COMPETITIVE BENCHMARKING
10.6.1 OVERALL COMPANY FOOTPRINT
TABLE 61 OVERALL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.6.2 PRODUCT FOOTPRINT
TABLE 62 PRODUCT FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.6.3 REGIONAL FOOTPRINT
TABLE 63 REGIONAL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.7 COMPETITIVE SCENARIOS AND TRENDS (2020–2023)
10.7.1 KEY PRODUCT LAUNCHES AND APPROVALS
TABLE 64 KEY PRODUCT LAUNCHES AND APPROVALS
10.7.2 KEY DEALS
TABLE 65 KEY DEALS
10.7.3 OTHER KEY DEVELOPMENTS
TABLE 66 OTHER KEY DEVELOPMENTS
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 67 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 30 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)
11.2 ELEKTA
TABLE 68 ELEKTA: COMPANY OVERVIEW
FIGURE 31 ELEKTA: COMPANY SNAPSHOT (2022)
11.3 ACCURAY INCORPORATED
TABLE 69 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 32 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022)
11.4 IBA WORLDWIDE
TABLE 70 IBA WORLDWIDE: COMPANY OVERVIEW
FIGURE 33 IBA WORLDWIDE: COMPANY SNAPSHOT (2022)
11.5 HITACHI, LTD.
TABLE 71 HITACHI, LTD.: COMPANY OVERVIEW
FIGURE 34 HITACHI, LTD.: COMPANY SNAPSHOT (2021)
11.6 MEVION MEDICAL SYSTEMS
TABLE 72 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
11.7 KONINKLIJKE PHILIPS N.V.
TABLE 73 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.8 RAYSEARCH LABORATORIES
TABLE 74 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 36 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
11.9 BRAINLAB AG
TABLE 75 BRAINLAB AG: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SCOPE
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 RECESSION IMPACT: INTENSITY-MODULATED RADIATION THERAPY MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
FIGURE 2 KEY DATA FROM SECONDARY SOURCES
2.1.2.2 Breakdown of primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation
FIGURE 6 COMPANY REVENUE ESTIMATION: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.2.1.2 Customer-based market estimation
FIGURE 7 BOTTOM-UP APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.2.2 TOP-DOWN APPROACH
2.2.3 PRIMARY INTERVIEWS
FIGURE 8 TOP-DOWN APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET
2.3 MARKET ESTIMATION AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 ASSUMPTIONS
2.5.1 STUDY ASSUMPTIONS
2.5.2 ASSUMPTIONS FOR GROWTH FORECAST MODEL
2.6 RISK ASSESSMENT
2.7 IMPACT OF RECESSION ON INTENSITY-MODULATED RADIATION THERAPY MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY REGION, 2022
4 PREMIUM INSIGHTS
4.1 INTENSITY-MODULATED RADIATION THERAPY MARKET OVERVIEW
FIGURE 14 INCREASING PREVALENCE OF CANCER AND GROWING GERIATRIC POPULATION TO DRIVE MARKET
4.2 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE AND COUNTRY
FIGURE 15 PHOTON RADIATION AND US COMMANDED LARGEST MARKET SHARE IN 2022
4.3 REGIONAL SNAPSHOT OF INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 16 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic diseases among all age groups
FIGURE 18 NEW CANCER CASES GLOBALLY, 2020
5.2.1.2 Advancements in radiation therapy technologies to improve treatment and reduce side effects
5.2.1.3 Improved patient outcomes and potential cost savings in long run
5.2.1.4 Reduced infection risk and shorter recovery periods with minimal scarring
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled radiologists/oncologists for operating automated radiotherapy equipment
5.2.2.2 High cost of intensity-modulated radiation therapy systems
5.2.3 OPPORTUNITIES
5.2.3.1 Rapid economic development and rising healthcare expenditure across emerging economies
5.2.3.2 Growing government and private investments in cancer treatment
5.2.3.3 Increased adoption of radiation therapy as primary treatment option for cancer
5.2.4 CHALLENGES
5.2.4.1 Increased risk of radiation exposure for both patients and healthcare staff
5.2.4.2 Increased competition from alternative treatment modalities
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTENSITY-MODULATED RADIATION THERAPY PRODUCTS
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
5.5.1 US
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPEAN COUNTRIES
5.5.3 JAPAN
TABLE 4 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6 REIMBURSEMENT SCENARIO ANALYSIS
TABLE 5 CPT CODES FOR MAJOR INTENSITY-MODULATED RADIATION THERAPY PROCEDURES
TABLE 6 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022
5.7 ECOSYSTEM MARKET MAP
FIGURE 19 ECOSYSTEM MARKET MAP: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.8 VALUE CHAIN ANALYSIS
5.8.1 TECHNOLOGY INNOVATION
5.8.2 PROCUREMENT AND PRODUCT DESIGN
5.8.3 MARKETING, SALES, AND DISTRIBUTION AND POST-SALES SERVICES
FIGURE 20 VALUE CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED COMPANIES
5.9.3 END USERS
FIGURE 21 SUPPLY CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
5.10 PRICING ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 22 TOP 10 PATENT APPLICANTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 23 TOP 10 PATENT OWNERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
5.12 TECHNOLOGY ANALYSIS
TABLE 7 IMPORTANT PRODUCT LAUNCHES IN INTENSITY-MODULATED RADIATION THERAPY MARKET (JANUARY 2015–JUNE 2022)
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 8 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2023–2024)
6 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION
6.1 INTRODUCTION
TABLE 9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
6.2 PROSTATE CANCER
6.2.1 ADVANCEMENTS IN NONINVASIVE RADIATION THERAPY TECHNOLOGY TO DRIVE MARKET
TABLE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION)
6.3 BREAST CANCER
6.3.1 LIFESTYLE CHANGES AND FOCUS ON EARLY DETECTION THROUGH SCREENING PROGRAMS TO DRIVE MARKET
TABLE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
6.4 LUNG CANCER
6.4.1 INCREASING RESEARCH AND CLINICAL TRIAL ACTIVITY TO DRIVE MARKET
TABLE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION)
6.5 GASTROINTESTINAL CANCER
6.5.1 RISING CONSUMPTION OF SALT-PRESERVED FOOD AND ALCOHOL TO DRIVE MARKET
TABLE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2021–2028 (USD MILLION)
6.6 BRAIN CANCER
6.6.1 NEGLIGENCE IN PRE-SCREENING PROCEDURES TO LIMIT MARKET
TABLE 14 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BRAIN CANCER, BY REGION, 2021–2028 (USD MILLION)
6.7 OTHER CANCERS
TABLE 15 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2021–2028 (USD MILLION)
7 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE
7.1 INTRODUCTION
TABLE 16 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
7.2 PHOTON RADIATION
7.2.1 RISING CANCER CASES GLOBALLY TO DRIVE MARKET
TABLE 17 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PHOTON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.3 ELECTRON RADIATION
7.3.1 TECHNIQUE LIMITATIONS AND REDUCED TREATMENT EFFECTIVENESS TO LIMIT ADOPTION
TABLE 18 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR ELECTRON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.4 PROTON RADIATION
7.4.1 EASY, PRECISE DOSAGE DELIVERY TO CANCEROUS TISSUES TO DRIVE USAGE
TABLE 19 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROTON RADIATION, BY REGION, 2021–2028 (USD MILLION)
7.5 CARBON-ION RADIATION
7.5.1 NEED FOR SPECIALIZED FACILITIES AND TREATMENT ROOMS FOR HEAVY ION-BASED THERAPIES TO LIMIT MARKET
TABLE 20 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR CARBON-ION RADIATION, BY REGION, 2021–2028 (USD MILLION)
8 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER
8.1 INTRODUCTION
TABLE 21 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 RAPID ADOPTION OF INVASIVE TECHNOLOGIES AND INCREASED NUMBER OF CANCER PATIENTS TO DRIVE MARKET
TABLE 22 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
8.3 INDEPENDENT RADIOTHERAPY CENTERS
8.3.1 LOWER OVERHEAD COSTS AND SHORTER WAITING PERIOD TO DRIVE MARKET
TABLE 23 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION)
9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 24 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT
TABLE 25 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 US dominated North American intensity-modulated radiation therapy market in 2022
TABLE 29 US: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Increasing prevalence of cancer and high demand for timely diagnosis to drive market
TABLE 30 CANADA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 31 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 33 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Increasing geriatric population and rising life expectancy to drive market
TABLE 35 GERMANY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing government initiatives for better healthcare practices to drive market
TABLE 36 FRANCE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 High burden of cancer and rising preference for noninvasive cancer management to drive market
TABLE 37 UK: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Increasing geriatric population and rising use of noninvasive cancer treatment methods to drive market
TABLE 38 ITALY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing technological developments in healthcare to drive market
TABLE 39 SPAIN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 40 REST OF EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT
TABLE 41 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 JAPAN
9.4.2.1 Increased geriatric population and presence of well-established healthcare sector to drive market
TABLE 45 JAPAN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Growing prevalence of cancer and developing healthcare infrastructure to drive market
TABLE 46 CHINA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing target patient population and rising availability of advanced surgical treatments to drive market
TABLE 47 INDIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Developing healthcare sector with increasing availability of advanced surgical and imaging procedures to drive market
TABLE 48 AUSTRALIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Growing target cancer patient population and increasing awareness of early cancer diagnosis to drive market
TABLE 49 SOUTH KOREA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 50 REST OF ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 51 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 53 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market
TABLE 55 BRAZIL: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Favorable government initiatives and low-cost manufacturing advantages to drive market
TABLE 56 MEXICO: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 57 REST OF LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 FAVORABLE GOVERNMENT INITIATIVES AND ECONOMIC GROWTH TO DRIVE MARKET
TABLE 58 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET
FIGURE 26 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2019–2023)
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022)
10.4 MARKET SHARE ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY KEY PLAYER (2022)
FIGURE 28 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2022
10.5 COMPANY EVALUATION MATRIX FOR PLAYERS (2022)
10.5.1 STARS
10.5.2 PERVASIVE PLAYERS
10.5.3 EMERGING LEADERS
10.5.4 PARTICIPANTS
FIGURE 29 COMPANY EVALUATION MATRIX FOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET, 2022
10.6 COMPETITIVE BENCHMARKING
10.6.1 OVERALL COMPANY FOOTPRINT
TABLE 61 OVERALL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.6.2 PRODUCT FOOTPRINT
TABLE 62 PRODUCT FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.6.3 REGIONAL FOOTPRINT
TABLE 63 REGIONAL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET
10.7 COMPETITIVE SCENARIOS AND TRENDS (2020–2023)
10.7.1 KEY PRODUCT LAUNCHES AND APPROVALS
TABLE 64 KEY PRODUCT LAUNCHES AND APPROVALS
10.7.2 KEY DEALS
TABLE 65 KEY DEALS
10.7.3 OTHER KEY DEVELOPMENTS
TABLE 66 OTHER KEY DEVELOPMENTS
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 67 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 30 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)
11.2 ELEKTA
TABLE 68 ELEKTA: COMPANY OVERVIEW
FIGURE 31 ELEKTA: COMPANY SNAPSHOT (2022)
11.3 ACCURAY INCORPORATED
TABLE 69 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 32 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022)
11.4 IBA WORLDWIDE
TABLE 70 IBA WORLDWIDE: COMPANY OVERVIEW
FIGURE 33 IBA WORLDWIDE: COMPANY SNAPSHOT (2022)
11.5 HITACHI, LTD.
TABLE 71 HITACHI, LTD.: COMPANY OVERVIEW
FIGURE 34 HITACHI, LTD.: COMPANY SNAPSHOT (2021)
11.6 MEVION MEDICAL SYSTEMS
TABLE 72 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
11.7 KONINKLIJKE PHILIPS N.V.
TABLE 73 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.8 RAYSEARCH LABORATORIES
TABLE 74 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 36 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
11.9 BRAINLAB AG
TABLE 75 BRAINLAB AG: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
